Nadim Ahmed - 06 Jun 2022 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role: President and CEO, Director
Signature: /s/ Jeffrey Trigilio, Attorney-in-Fact
Issuer symbol: CGEM
Transactions as of: 06 Jun 2022
Net transactions value: +$100,316
Form type: 4
Filing time: 07 Jun 2022, 16:33:16 UTC
Previous filing: 07 Mar 2022
Next filing: 05 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGEM	Common Stock	Purchase	$100,316	+8,090		$12.40	8,090	06 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.34 to $12.45. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.34 to $12.45. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.